Botvinik-Nezer · Nature communications 2024 · experimental fMRI study · n=392

Placebo treatment affects brain systems related to affective and cognitive processes, but not nociceptive pain.

Level 2 - randomized trial

Individual experimental neuroimaging trial in human participants

PubMed 39019888 · doi:10.1038/s41467-024-50103-8 · record verified 2026-08-26

What was done

Researchers conducted a pre-registered functional magnetic resonance imaging (fMRI) study in 392 participants to evaluate whether placebo analgesic treatment modulates nociceptive processes and whether its effects generalize from conditioned thermal pain to unconditioned mechanical pain. Neural outcomes were assessed using pre-defined neuroimaging markers, including the nociceptive Neurologic Pain Signature (NPS), spinothalamic pathway regions, the higher-level Stimulus Intensity Independent Pain Signature (SIIPS), and brain regions related to motivation and value.

What was found

The abstract reports no exact numerical values, percentages, or Bayes factor statistics. Placebo treatment produced robust analgesia in conditioned thermal pain that generalized to unconditioned mechanical pain. However, placebo did not decrease fMRI activity in the NPS or spinothalamic regions (supported by null effects in Bayes Factor analyses), and increased activity in some spinothalamic regions for unconditioned mechanical pain. In contrast, placebo reduced activity in the SIIPS and altered activity in motivation- and value-related regions across both modalities, with individual behavioral analgesia correlating with neural changes.

Why it matters

This study demonstrates that placebo analgesia operates primarily through cognitive and affective evaluative brain systems rather than by suppressing early nociceptive processing. It highlights the utility of specific neuromarkers to differentiate treatments acting directly on nociception from those acting on appraisal.

Limits

The abstract reports no numerical data, effect sizes, confidence intervals, or precise statistical outputs. Participant demographics, health status (such as healthy volunteers versus chronic pain patients), and specific randomization details are not described in the abstract.